Skip to content
InsideEdge
Investors / filer profile

Track record

What happened ~6 months after each disclosed buy

Not enough completed buys to draw the outcome line yet.

1 of 1
buys higher ~6mo later
+41.5%
median outcome
+2.3%
S&P 500 median, same spans

Disclosed positions

Estimated from their latest filings — positions may have changed since

$48.41M
combined est. value
LBRX
LB PHARMACEUTICALS INC
$48.41M
1,411,681 sh

Activity

Open-market buy & sell volume

BuySell
0$42.5M$85.0M2025 · bought $15.0M · sold $85.0M2025
Total +$15.00M bought · −$84.98M sold
Most bought
LBRX
$15.00M

All filings on record

Every Form 4 transaction we track for this filer

KROSSell
2025-10-15 · Keros Therapeutics, Inc.
$2.76M
—
KROSSell
2025-10-15 · Keros Therapeutics, Inc.
$21.77M
—
KROSSell
2025-10-15 · Keros Therapeutics, Inc.
$19.90M
—
KROSSell
2025-10-15 · Keros Therapeutics, Inc.
$40.55M
—
LBRXBuy
2025-09-12 · LB PHARMACEUTICALS INC
$15.00M
+41.5%
LBRXConvert
2025-09-12 · LB PHARMACEUTICALS INC
411,681
—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.